Literature DB >> 6912385

Liberation of catecholamines and 5-hydroxytryptamine from human blood-platelets.

M Peyer, A Pletscher.   

Abstract

Spontaneous and drug-induced liberation of 14C-5-hydroxytryptamine (14C-5HT), 3H-dopamine (3H-DA) and 3H-noradrenaline (3H-NA) from normal and reserpinized human blood-platelets has been determined from measurements of the amine contents before and after incubation in tris-buffer. In normal platelets the spontaneous liberation of 3H-catecholamines was more marked than that of 14C-5HT, but was less in percent for all these labelled amines than in reserpinized platelets. Thrombin lowered amine contents more in normal than in reserpinized platelets. The initial thrombin-induced decrease of 14C-5HT, in contrast to that of 3H-catecholamines, showed a partial recovery after 30 min which was abolished by imipramine. The benzoquinolizine Ro 4-1284 diminished all the amines in normal, but not in reserpinized platelets. In normal platelets tryamine affected 14C-5HT and 3H-DA about equally, whereas 3H-NA much less. Octopamine showed a similar pattern as tryamine, but was less potent. P-chlormethamphetamine (PCMA) and amphetamine decreased 3H-DA less markedly than 14C-5HT and 3H-NA not at all. In reserpinized platelets these arylalkylamines induced a decrease of 14C-5HT but not of 3H-catecholamines. It is concluded that (a) 3H-catecholamines like 14C-5HT are mainly localized in the granular pool of normal human platelets, (b) the pattern of action of a drug on intra- and extragranular amines depends not only on the nature of the drug and the amine to be liberated, but in comparison with previous results also on the species, (c) platelets are not completely satisfactory models for monoaminergic neurons, especially catecholaminergic ones regarding drug-induced amine liberation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6912385     DOI: 10.1007/bf00507232

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Release of serotonin and catecholamines by drugs.

Authors:  P A SHORE
Journal:  Pharmacol Rev       Date:  1962-12       Impact factor: 25.468

2.  Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs.

Authors:  A Laubscher; A Pletscher
Journal:  Life Sci       Date:  1979-05-14       Impact factor: 5.037

3.  Storage of exogenous monoamines and reserpine in 5-hydroxytryptamine organelles of blood platelets.

Authors:  M D Prada; A Pletscher
Journal:  Eur J Pharmacol       Date:  1969-07       Impact factor: 4.432

4.  On the mode of action of central stimulatory agents.

Authors:  S B Ross
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-10

5.  Dopamine is a monoamine oxidase B substrate in man.

Authors:  V Glover; M Sandler; F Owen; G J Riley
Journal:  Nature       Date:  1977-01-06       Impact factor: 49.962

6.  The efflux rate of norepinephrine from platelets and its relation to blood pressure.

Authors:  I Mattiasson; B Mattiasson; B Hood
Journal:  Life Sci       Date:  1979-06-11       Impact factor: 5.037

7.  In vitro and in vivo functions of thrombin-treated platelets.

Authors:  H J Reimers; R L Kinlough-Rathbone; J P Cazenave; A F Senyi; J Hirsh; M A Packham; J F Mustard
Journal:  Thromb Haemost       Date:  1976-02-29       Impact factor: 5.249

8.  Interactions between reserpine and various compounds on the accumulation of [14C] 5-hydroxytryptamine and [3H]noradrenaline in homogenates from rat hypothalamus.

Authors:  S B Ross
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

9.  Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.

Authors:  M Da Prada; G B Picotti
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

10.  Phase separation in solutions of noradrenaline and adenosine triphosphate: influence of bivalent cations and drugs.

Authors:  K H Berneis; A Pletscher; M Da Prada
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

View more
  1 in total

1.  Abnormal platelet aggregation response in Huntington's disease.

Authors:  Y Muramatsu; H Kaiya; H Imai; M Nozaki; H Fujimura; M Namba
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.